Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WESTLAKE CORP Director's Dealing 2017

Nov 15, 2017

30551_dirs_2017-11-15_5fe57547-b4ff-4d1c-8eef-5428513329f3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WESTLAKE CHEMICAL CORP (WLK)
CIK: 0001262823
Period of Report: 2017-11-13

Reporting Person: Mangieri George J (SVP & Chief Accounting Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-13 Common Stock M 3618 $45.6975 Acquired 10195 Direct
2017-11-13 Common Stock M 3028 $63.9775 Acquired 13223 Direct
2017-11-13 Common Stock M 1810 $44.420 Acquired 15033 Direct
2017-11-13 Common Stock M 2010 $68.09 Acquired 17043 Direct
2017-11-13 Common Stock S 10466 $94.3737 Disposed 6577 Direct
2017-11-13 Common Stock S 2915 $94.70 Disposed 3662 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-11-13 Employee Option (right to buy) $45.6975 M 3618 Disposed 2023-02-15 Common Stock (3618) Direct
2017-11-13 Employee Option (right to buy) $63.9775 M 3028 Disposed 2024-02-14 Common Stock (3028) Direct
2017-11-13 Employee Option (right to buy) $44.420 M 1810 Disposed 2026-02-18 Common Stock (1810) Direct
2017-11-13 Employee Option (right to buy) $68.090 M 2010 Disposed 2025-02-20 Common Stock (2010) Direct

Footnotes

F1: The stock options are excercisable in three installments of 33%, 33% and 34% on February 15, 2014, 2015 and 2016, respectively.

F2: The stock options are excercisable in three installments of 33%, 33% and 34% on February 14, 2015, 2016 and 2017, respectively.

F3: The stock options are excercisable in three installments of 33%, 33% and 34% on February 18, 2017, 2018 and 2019, respectively.

F4: The stock options are excercisable in three installments of 33%, 33% and 34% on February 20, 2016, 2017 and 2018, respectively.

F5: In accordance with the Securities and Exchange Commission's No Action Letter dated June 25, 2008, we have aggregated the sales that occurred on November 13, 2017 for ease of reporting. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $94.00 to $94.70, inclusive. The reporting person undertakes to provide to Westlake Chemical Corp., any security holder of Westlake Chemical Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.